Drug price inflation outpaces general inflation, AARP study finds

Study examines branded, specialty, generic drug prices between 2005 and 2009

WASHINGTON — Prices for generic drugs may be dropping, but increases in branded and specialty drug prices have offset those decreases, according to a new study.

The study, conducted by AARP's Public Policy Institute, found that the cumulative change in drug prices from 2005 to 2009 was almost double the rate of inflation. As a result, the average annual cost of drug therapy continued to rise.

The study was based on examinations of retail prices for the 514 drugs most used by Medicare beneficiaries. In 2009, while the rate of general inflation was -0.3%, the drugs increased in price by an average of 4.8%. Branded drugs increased in price by 8.3%, while specialty drugs rose by 8.9% and generic drugs decreased by 7.8%.

"For the people who rely on these drugs, such relentless price increase have serious implications," AARP SVP public strategy Cheryl Matheis said. "Despite price reductions for generics, it's evident that the considerable increases in brand name and specialty drug prices are still leaving Americans with overall costs that are growing far faster than the rate of inflation."

For the 469 drugs on the market since the end of 2004, prices increased by 25.6% from 2005 to 2009, while the general inflation rate was 13.3%. Consumers taking drugs to treat chronic diseases found that their average annual cost increased from $2,160 to $3,168.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

Recommended stories

Comments

- 12:25 PM
maours says

My anger grows every day I work seeing Medicaid patients pick up these medications for a little bit of nothing when we have to call doctors and switch prescribed medications to "something cheaper" for working (insured) patients who can't afford to pay for these even if the second choice medication may not be as effective for them.

Login or Register to post a comment.